Vaccine Contract Manufacturing Market Research Report Information By Vaccine Type (Attenuated, Inactivated, Subunit-based, Toxoid-based and DNA-based), By Workflow (Downstream and Upstream), By Application (Human Use and Veterinary), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE

6.1. Overview

6.2. Attenuated

6.3. Inactivated

6.4. Subunit-based

6.5. Toxoid-based

6.6. DNA-based

7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW

7.1. Overview

7.2. Downstream

7.3. Upstream

8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION

8.1. Overview

8.2. Human Use

8.3. Veterinary

9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Vaccine Contract Manufacturing Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Vaccine Contract Manufacturing Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Emergent BioSolutions Inc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Catalent, Inc.

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Lonza Group AG

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Fujifilm Diosynth Biotechnologies

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Wuxi Biologics

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Samsung Biologics

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Boehringer Ingelheim

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Novavax, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. BioNTech SE

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. CSL Limited

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 US: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 10 US: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 11 US: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 CANADA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 13 CANADA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 14 CANADA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 10 ITALY: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 11 ITALY: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 12 ITALY: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 16 UK: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 17 UK: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 18 UK: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 28 CHINA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 29 CHINA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 30 CHINA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 31 INDIA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 32 INDIA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 33 INDIA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VACCINE CONTRACT MANUFACTURING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VACCINE CONTRACT MANUFACTURING MARKET

FIGURE 4 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY VACCINE TYPE, 2023

FIGURE 5 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY WORKFLOW, 2023

FIGURE 6 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 7 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: VACCINE CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 EMERGENT BIOSOLUTIONS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 EMERGENT BIOSOLUTIONS INC.: SWOT ANALYSIS

FIGURE 15 CATALENT, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 CATALENT, INC.: SWOT ANALYSIS

FIGURE 17 LONZA GROUP AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 LONZA GROUP AG: SWOT ANALYSIS

FIGURE 19 FUJIFILM DIOSYNTH BIOTECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 FUJIFILM DIOSYNTH BIOTECHNOLOGIES: SWOT ANALYSIS

FIGURE 21 WUXI BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 WUXI BIOLOGICS: SWOT ANALYSIS

FIGURE 23 SAMSUNG BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 SAMSUNG BIOLOGICS: SWOT ANALYSIS

FIGURE 25 BOEHRINGER INGELHEIM: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 BOEHRINGER INGELHEIM: SWOT ANALYSIS

FIGURE 27 NOVAVAX, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 NOVAVAX, INC.: SWOT ANALYSIS

FIGURE 29 BIONTECH SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 BIONTECH SE: SWOT ANALYSIS

FIGURE 31 CSL LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 CSL LIMITED: SWOT ANALYSIS